Effects of indomethacin, 5,8,11,14-eicosatetraynoic acid, and p-bromophenacyl bromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes.
D015117:5,8,11,14-Eicosatetraynoic Acid / Q000494:pharmacology*; D000098:Acetophenones / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D000431:Ethanol / Q000494:pharmacology; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology*; D005966:Glucuronidase / Q000037:antagonists & inhibitors; D006801:Humans; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology*; D007770:L-Lactate Dehydrogenase / Q000037:antagonists & inhibitors; D008247:Lysosomes / Q000201:enzymology*; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D010100:Oxygen / Q000378:metabolism*; D010740:Phospholipases / Q000037:antagonists & inhibitors*; D010741:Phospholipases A / Q000037:antagonists & inhibitors*; D013481:Superoxides / Q000378:metabolism*
D000098:Acetophenones; D005231:Fatty Acids, Unsaturated; D013481:Superoxides; D015117:5,8,11,14-Eicosatetraynoic Acid; D000431:Ethanol; D007770:L-Lactate Dehydrogenase; D010740:Phospholipases; D010741:Phospholipases A; D005966:Glucuronidase; C006821:4-bromophenacyl bromide; D001241:Aspirin; D010100:Oxygen; D007213:Indomethacin